Olanzapine versus Ziprasidone: Quality-of-life changes in patients with schizophrenia

被引：0
|
作者：
Namioshi, M
Xu, W
Berg, PH
Roychowdhury, SM
Cavazzoni, P
Naber, D
Breier, A
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Univ Hamburg, Hamburg, Germany
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2003年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A50 / A50
页数：1
相关论文
共 50 条
  • [21] Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: A systematic review
    Matza, LS
    Baker, TM
    Revicki, DA
    CNS DRUGS, 2005, 19 (06) : 499 - 515
  • [22] PHARMACOGENETIC STUDIES OF OLANZAPINE, PERAZINE AND ZIPRASIDONE IN PARANOID SCHIZOPHRENIA
    Samochowiec, J.
    Tybura, P.
    Frydecka, D.
    Beszlej, A.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [23] INTERPRETATION OF QUALITY-OF-LIFE CHANGES
    LYDICK, E
    EPSTEIN, RS
    QUALITY OF LIFE RESEARCH, 1993, 2 (03) : 221 - 226
  • [24] CHANGES IN QUALITY-OF-LIFE IN RHEUMATIC PATIENTS WITH JOINT REPLACEMENT - COMPARISON OF GENERIC VERSUS SPECIFIC INSTRUMENTS
    DIAZBORJON, E
    MARCIALBARBA, LD
    CARDIEL, MH
    HERNANDEZCRUZ, BE
    RUIZMERCADO, R
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 74 - 74
  • [25] EARLY VERSUS LATE PERCEPTION OF QUALITY-OF-LIFE CHANGES IN THERAPY-RESISTANT EPILEPSY PATIENTS
    DERRY, P
    WIEBE, S
    ROSE, K
    EPILEPSIA, 1995, 36 : 430 - 430
  • [26] Quality-of-life assessment in schizophrenia: the unfulfilled promise
    Awad, A. George
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (05) : 491 - 493
  • [27] Measures of Functional Status and Quality-of-Life in Schizophrenia
    Price, Mark A.
    Hill, Cheryl D.
    Williams, Valerie S. L.
    Morlock, Robert J.
    Leeuwenkamp, Oscar
    Patterson, Thomas L.
    CURRENT PSYCHIATRY REVIEWS, 2008, 4 (01) : 28 - 38
  • [28] MEASUREMENT OF QUALITY-OF-LIFE CHANGES IN PATIENTS WITH ALZHEIMERS-DISEASE
    DEJONG, R
    OSTERLUND, OW
    ROY, GW
    CLINICAL THERAPEUTICS, 1989, 11 (04) : 545 - 554
  • [29] QUALITY-OF-LIFE MEASURES IN COPD PATIENTS - CHANGES OVER TIME
    COTTRELL, JJ
    PAUL, C
    FERSON, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A530 - A530
  • [30] A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
    Kinon, BJ
    Lipkovich, I
    Edwards, SB
    Adams, DH
    Ascher-Svanum, H
    Siris, SG
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) : 157 - 162
12345